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Methods for screening mutations that affect the synthesis of 
plant small molecules or compounds capable of activating a 
mammalian nuclear receptor protein and systems for rapidly 
assigning functionality to genes that regulate plant secondary 
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METHODS FOR SCREENING FOR GENES 
AND SMALL MOLECULES THAT ACTIVATE 
MAMMALIAN RECEPTOR PROTEINS 
FIELD OF THE INVENTION 
The invention relates to methods for screening mutations 
that affect the synthesis of plant small molecules or com 
pounds capable of activating a mammalian nuclear receptor 
protein. More particularly, the invention relates to the use of 
transgenic plants encoding a mammalian receptor Whose acti 
vation is linked to a gene encoding a visible reporter gene to 
identify genes encoding small molecules or compounds that 
activate the receptor. 
BACKGROUND OF THE INVENTION 
Plants produce many small molecules With speci?c and 
potent biological activity. These are commonly economically 
important, either because they are valuable commercial prod 
ucts, or because they have regulatory functions as plant hor 
mones or intracellular messengers. The genetic regulation of 
the synthesis of such compounds is often unknown. For 
example only a small fraction of the Arabidopsis genome is 
recogniZed as being involved in plant secondary metabolism. 
The problems in elucidating these pathWays include loW 
accumulation levels, transient or tissue-speci?c expression, 
or the complications associated With long multi-step path 
Ways. To overcome these problems a strategy has been 
devised combining activation tagging mutagenesis (ATM) 
With pharmacological high throughput screening (HTS). In 
this, ATM of Nicoliana Zabacum protoplasts are used to pro 
duce a mutant population of microcallus cultures, and indi 
vidual clones that over-accumulate products With a speci?c 
biological activity are then selected after HTS. These mutant 
clones are then used to isolate the tagged genes responsible 
for this accumulation. This enables product-relevant genes to 
be identi?ed Without the requirement for understanding the 
metabolic pathWay. HoWever, because of the random nature 
of ATM, and the large genome siZe, as many as 300,000 
individual mutants Would need to be screened to cover the 
entire genome. Thus, there is a need for systems and methods 
to signi?cantly increase screening throughput. 
SUMMARY OF THE INVENTION 
In one aspect of the invention there is provided a method 
for screening mutations that affect the synthesis of plant small 
molecules or compounds capable of activating a mammalian 
nuclear receptor proteins comprising 
(1) transforming a plant With a vector comprising a consti 
tutive promoter operably linked to the mammalian nuclear 
receptor ligand binding domain Which is operably linked to a 
transcription factor DNA binding domain and a transactivat 
ing transcriptional activator domain; and a gene encoding a 
visible marker operably linked to a transcription activator 
sequence and a promoter, to obtain a transgenic plant; 
(2) isolating protoplasts from the transgenic plant; 
(3) mutageniZing the protoplasts to form mutageniZed pro 
toplasts; 
(4) culturing the mutageniZed protoplasts into microcalli; 
and 
(5) selecting microcalli that overexpress the visible marker 
gene. 
In another aspect of the invention there is provided a trans 
genic plant or plant tissue comprising a vector comprising a 
constitutive promoter operably linked to the mammalian 
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nuclear receptor ligand binding domain Which is operably 
linked to a transcription factor DNA binding domain and a 
transactivating transcriptional activator domain; and a gene 
encoding a visible marker operably linked to a transcription 
activator sequence and a promoter, Wherein the transgenic 
plant or plant tissue overexpresses the visible marker. 
In another aspect of the invention there is provided a plant 
cell line derived from the transgenic plant or plant tissue of the 
invention. 
BRIEF DESCRIPTION OF THE DRAWINGS 
FIG. 1 is a schematic draWing illustrating the elements of 
the nuclear receptor protein (NRP) inducible system. T-DNA 
is delineated by the right and left borders, labeled RB and LB 
in boxes at either end of the element. Block arroWs Within the 
element represent promoter sequences 35S from Cauli?ower 
mosaic virus; NOS, nopaline synthase promoter; 6X UAS, six 
tandem repeats of the yeast GAL4 upstream activator 
sequence folloWed by —46 to +1 region of the 35S promoter 
(encompassing the TATA box sequence). E91, polyadenyla 
tion addition sequence of the pea ribulose bisphosphate car 
boxylase small subunit gene E9; NOS], nopaline synthase 
poly(A) terminator sequence; 3A1, poly(A) addition 
sequence of the pea rbc S3A gene. GVG, gene encoding the 
trimeric glucocorticoid-inducible transcription factor. The 
yeast GAL4 protein is at the N-terminus, the transactivating 
domain from herpes simplex virus VP16 protein, and the 
hormone binding domain of the rat glucocorticoid receptor is 
at the C-terminus. 
FIG. 2A-D are photographs of the upper parts of leaves of 
an Arabidopsis transgenic line after treating the seedlings 
With the indicated concentration of various inducers. Seed 
lings Were exposed for 48 hours before vieWing under blue 
(470 nm) Wavelength light at 40x magni?cation. A. Control. 
Leaf surface With no inducer; or treated With 1 microMol 
dexamethasone (B); 30 microMol progesterone (C); or 30 
microMole hydrocortisone. 
FIGS. 3A-3D provide an example of GFP ?uorescence 
from induced single protoplasts derived from glucocorticoid 
NRP transgenic tobacco. TWo-day-old cells Were induced for 
20 hours With 10 microMol dexamethasone before photo gra 
phy. A. Protoplasts at 40x magni?cation. B. and C. l00>< 
magni?cation. D. Photograph of elongating cells in same dish 
taken three days later at l00><. All green color is due to GFP 
?uorescence. Chloroplasts are evident as small red dots as 
chlorophyll auto?uoresces under blue Wavelength light. Yel 
loWish spots in some cells are nuclei that are actually ?uo 
rescing intensely green but appear yelloW from the length 
ened exposure times used to enable the green ?uorescence in 
the cytoplasm to be captured on ?lm. Although not shoWn, 
non-induced Wild type cells display only red auto?uores 
cence and no green coloration. 
DETAILED DESCRIPTION OF THE INVENTION 
This invention provides methods and systems for signi? 
cantly increasing screening throughput of mutants by using 
the plant cell itself to screen for biological activity. To this 
end, transgenic lines of N. Zabacum and Arabidopsis have 
been engineered to express nuclear receptor proteins (N RPs) 
that are linked to the expression of a visible marker protein, 
e.g., green ?uorescent protein (GFP) or luciferase. Cells from 
this line exposed to activators of the NRP are identi?able by 
visible screening, for example, under a ?uorescence micro 
scope for the accumulation of GFP. These transgenic lines are 
used to produce a population of mutant protoplasts by ATM, 
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and individual cells that over-accumulate relevant products 
are identi?ed by marker protein, e. g., GFP expression. Each 
“positive” cell line may be used to identify the type of com 
pound responsible for the biological activity, and for recovery 
of genomic DNA adjacent to the activation T-DNA tag (plas 
mid rescue, genomic Walking). Candidate sequences are 
evaluated for their ability to reproduce the marker-positive 
phenotype, e.g., GFP-positive When inserted into protoplasts, 
and may be sequenced by high throughput DNA sequencing. 
Overexpression of the positive genetic material is evaluated 
in Whole plants to establish its metabolic impact at this level. 
In particular, the focus is on products With biological activity 
at mammalian nuclear receptor proteins, such as corticoster 
oid NRP, Liver X receptor, estrogen NRP, glucocorticoid, 
mineralcorticoid, androgen, progesterone group, famesoid X 
receptor, vitamin D receptor, and peroxisome proliferator 
activated receptor (PPAR). These NRPs are knoWn to respond 
to speci?c sterol products of plant secondary metabolism, and 
have knoWn sequences and pharmacological pro?les. HoW 
ever, the systems and methods described herein are adaptable 
and applicable to many small molecule plant metabolites With 
biological activity. Although many of the genes identi?ed by 
this strategy may have only indirect effects on the pathWays 
leading to the biologically active products, their characteriza 
tion Will help elucidate regulation of secondary metabolism. 
Similarly, characterization of the T-DNA and ?anking 
sequences Will provide neW information regarding gene 
structure and organiZation. 
The methods and systems provided by this invention aim to 
functionally identify a broad range of genes that in?uence the 
production of plant metabolites. The genes identi?ed by these 
methods are uncovered in a forward fashion, that is, the effect 
of the overexpressed genes on the production of metabolites, 
including secondary metabolites, in plant cells is observed. 
Upregulated expression of genes as a result of the mutagen 
esis step employed in the methods leads to an increased 
synthesis of a class of plant metabolites. Consequently, an 
important functional characteristic of the tagged genes is 
provided immediately. Speci?cally, overexpression of the 
identi?ed gene leads to increased production of the small 
molecule activity (in comparison to production of activity 
detected in a Wild-type plant). While the total number of plant 
genes that in?uences the synthesis of compounds in this Way 
may not be large, this approach Will result in the identi?cation 
of any gene Which exerts this effect. Thus the primary iden 
ti?cation of each tagged gene is determined on this functional 
basis. 
The types of genes that may be identi?ed using the genet 
ics-based methods of the invention are conceivably broad. 
Because any gene Whose overexpression leads to pathWay 
upregulation can be isolated, genes encoding products that 
function as pathWay regulators, in signaling, or as pathWay 
speci?c enZymes are possible candidates. Many features of 
plant secondary metabolism make this one of the most sig 
ni?cant aspects of this strategy. The biosynthetic pathWays 
that lead to the production of secondary compounds are 
highly diverse and complex, often requiring a large number of 
enZymatic steps and multiple regulatory layers. For thor 
oughly studied pathWays, it is noW Well documented that 
developmental, temporal and tissue-level control are com 
mon regulatory mechanisms for such natural product path 
Ways. All of these forms of regulation are evident from 
research conducted on a variety of plant speci?c pathWays. 
One example is the biosynthesis of terpenoids (McGarvey 
and Croteau 1995), Which includes a vast assortment of aro 
matics and, in many species including Menlha, accumulate in 
glandular trichomes at speci?c developmental stages and 
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times. All of the enZymes required for the synthesis of these 
MenZha-speci?c terpenoids are expressed exclusively in glan 
dular cells With the primary mechanism of regulation occur 
ring at the transcriptional level (Lange et al. 2000, Proc. Natl. 
Acad. Sci USA, 97:2934-9; McCaskill and Croteau 1995, 
Planta, 197149-56). 
The present methods and systems alloW for screening of 
extremely high numbers of cells harboring distinct activation 
mutations. Considering the genome siZe of plants, such as 
Nicoliana Zabacum and Arabidopsis, Which are particularly 
Well suited for such studies, such high throughput screening 
capacity is essential. The experimental strategy transforms 
the desired phenotype, that of elevated accumulation of plant 
derived molecules, to a visible response su?iciently sensitive 
to permit detection at an individual cell stage. A functional 
approach is thus applied in tWo respects, that of the biological 
activity of the plant molecule itself and of the genes that exert 
this upregulation. This approach yields distinct, neW 
resources and information. It also makes available a 
mutageniZed population of plant tissue and Whole plants that 
can be studied further, and it Will provide the genomic data 
concerning the overexpres sed genes that lead to the increased 
biological activity. Also, because the plant sequences are 
isolated as genomic clones associated With a T-DNA tag, 
additional genomic sequence information Will be obtained. 
Details regarding gene redundancy, density and organiZation 
Will also be elucidated. The derived sequences of a particular 
plant in Which the studies are conducted Will be informative 
for comparative analyses to other plant genomes such as 
Arabidopsis, rice and maiZe. Finally, the in?uence of each 
mutation on the physiology of Whole plants can be observed, 
once plant tissue is regenerated from screen-positive calli. 
An additional outcome of the high throughput screening 
methods and systems provided herein is that an inventory of 
sequences that in?uence speci?c small molecule synthesis 
Will be made available. Such a collection of genes Will help to 
address questions relating to hoW pathWays that lead to small 
molecule synthesis are signaled. In a handful of pathWays 
Well elucidated at the biochemical and genetic levels, 
metabolite accumulation in response to an inductive signal 
has been shoWn to be the consequence of upregulation of both 
the immediate biosynthetic pathWay as Well as the preceding, 
“supply” pathWays. This coordinated expression among the 
requisite, distinct pathWays involved in the synthesis of a 
given plant metabolite is probably common. For example, the 
tryptophan pathWay supplies precursors for subsequent, sec 
ondary pathWays and a study of its regulation provides 
experimental support for this phenomenon. Genes encoding 
enZymes of the tryptophan pathWay Were found to be upregu 
lated in concert to meet the increased demands for synthesis 
of the secondary metabolite camalexin, an indolic phytoal 
exin, derived from tryptophan (Zhao and Last 1996, Plant 
Cell, 812235-2244). This ?nding demonstrated that distinct 
primary and secondary pathWays are interlinked and co-regu 
lated to respond to the requirements for synthesis of a sec 
ondary metabolite. A mechanistic explanation for Whole 
pathWay coordination is suggested by the recent discovery of 
a transcriptional regulator, ATRl, Which has been shoWn to 
control expression for the ?rst step in the tryptophan pathWay 
(Bender and Pink 1998, Proc. Natl. Acad. Sci. USA, 95:5655 
5560). This Myb-like transcription factor positively regulates 
expression of anthranilate synthase and perhaps additional 
genes Within the tryptophan and related secondary pathWays. 
The increased production of ?avonoids in response to irra 
diation With ultraviolet light provides another example for 
multiple pathWay regulation. Genes Within the primary shiki 
mate pathWay and the secondary ?avonoid pathWay Were 
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found to be selectively coinduced, re?ecting an integrated 
response to enable rapid metabolite accumulation Without 
depleting intermediates from the respective pathWays (Lo ge 
mann et al. 2000, Proc. Natl. Acad. Sci. USA, 97: 1 903-1907). 
Thus an emerging vieW is that supply, generally primary, 
pathWays are appropriately coordinated to maintain homeo 
stasis When products or precursors from them are channeled 
into the production of neW metabolites (Y ao et al. 1995,Plant 
Cell, 711787-1799). 
Another example of hoW a single gene regulator mediates 
changes in small molecule metabolism Was provided by the 
isolation of the transcription factor, ORCA3, from Calharan 
thus roseus. Overexpression of this regulator results in the 
overexpression of a number of metabolite biosynthetic genes 
from more than one pathWay and in turn results in the accu 
mulation of terpenoid indole alkaloid products. The Orca3 
regulator also has a role in signaling as it provides for a 
mechanism that links small-molecule synthesis to cellular 
stresses indicated by the level of jasmonic acid. Finally, and of 
relevance to the mutagenic approach to be used here, the 
ORCA3 gene Was isolated by activation T-DNA tagging in a 
positive selection procedure, again demonstrating that path 
Way regulators are possible gene candidates With this type of 
mutagenesis. 
The basic method for activation mutagenesis has been 
knoWn for several years (FritZe and Walden 1995, Meth. Mol. 
Biol., 441281-294; FritZe et al. 1995, Plant 1., 71261-271; 
Walden et al. 1995, Meth. Cell Biol., 491455-469, each incor 
porated herein by reference). In this technique, enhancer 
sequences from the Cauli?ower mosaic virus 35S promoter 
are incorporated (via A grobacteri um mediated T-DNA trans 
fer) at random into the plant genome, and produce activation 
of genes in the immediate vicinity of the incorporated DNA. 
Because the enhancers cause deregulation of promoters 
nearby, gene overexpression generally results, usually con 
ferring a dominant, gain-of-function mutation that is imme 
diately scorable, making this mutagenesis technique ideally 
suited for conducting screens at the callus or individual cell 
level. Activation of promoters has been found to occur up to 
3.6-kb from the T-DNA insert inArabidopsis and the enhanc 
ers function independent of orientation, leading to gene over 
expression either upstream or doWnstream from the T-DNA 
integration site (Weigel et al. 2000). In addition, because the 
relevant locus is “tagged” With the inserted T-DNA element, 
a variety of techniques exist to enable the straightforWard 
recovery of the associated genomic DNA, including plasmid 
rescue, probably one of the most e?icient genomic cloning 
techniques available. This very poWerful mutagenesis tech 
nique has been applied most successfully using positive 
genetic selection procedures, such as survival of cells or 
tissue in the presence of speci?c inhibitors for essential 
enZymes (FritZe et al. 1995), in the absence of required 
groWth factors (Kakimoto 1996, Science, 2741982-5) or 
under restrictive groWth conditions (Furini et al. 1997, 
EMBO 1., 1613599-608). Recently, Whole plant screens con 
ducted primarily With Arabidopsis have resulted in the isola 
tion of a number of genes involving developmental processes 
or other mutations conferring visible phenotypes (BorevitZ et 
al. 2000, Plant Cell, 1212383-2394; Huang et al. 2001, Plant 
Physiol., 1251573-584; Kardailsky et al. 1999, Science, 2861 
1962-5; Weigel et al. 2000, Plant Physiol., 12211003-13). 
Thus activation T-DNA tagging has proved effective for the 
isolation of a Wide range of different genes in several different 
plant species. HoWever, the use of it to create mutations that 
lead to the accumulation of active metabolites that confer no 
visible phenotype previously has not been accomplished. 
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The present activity-based screen is conducted at the level 
of microcallus tissue, Which is derived from protoplasts 
mutageniZed by T-DNA gene activation. The primary steps of 
the screen are generally to nondestructively sample 
mutageniZed callus tissue, prepare a crude extract from this 
tissue sample and conduct assays for small-molecule activity. 
The essential property for small molecules of interest is that 
they bind to a mammalian receptor of interest, such as the 
glucocorticoid receptor, estrogen receptor, androgen recep 
tor, progesterone receptor, mineralocorticoid receptor, liver X 
receptor, for example, present in the plant. For these purposes, 
(identifying cultures that overproduce such compounds) it 
does not matter Whether the binding activity results in activa 
tion (agonists) or inhibition (antagonists) of receptor func 
tion. Thus the simplest Way of testing for such compounds is 
by a radioligand displacement assay (Gattu et al. 1995, J. 
Neurosci. Meth., 631121-125; incorporated herein by refer 
ence). In this method, a compound that binds With a very high 
a?inity and selectivity to the desired NRP is radiolabeled and 
alloWed to equilibrate With a membrane fraction containing 
the NRP. When unlabelled compounds that also bind to the 
NRP are present there is competition for the binding sites 
betWeen these and the labeled ligand. As a result, less radio 
label Will associate With the membranes. 
Other processes that may be used in the present invention 
include methodologies to propagate, array and sample the 
mutated plant, e.g., callus tissue derived from individual pro 
toplasts. Mutated cells are prepared by transformation of 
freshly isolated leaf protoplasts by co-cultivation With Agro 
baclerium harboring the activation-tagging T-DNA element. 
After this co-cultivation step, protoplasts are Washed and 
embedded Within a low-gelling temperature agarose to alloW 
development of the transformed protoplast cells, noW under 
antibiotic selection for the T-DNA, into microcalli. This gen 
erates the primary, mutated tissue in an agarose-embedded 
format in 60-mm petri dishes. Typically, 10 to 14 dishes per 
bimonthly experiment are generated, although the total num 
ber of transforrnants per dish, Which represents an individual 
co-cultivation event, in practice is highly variable. 
At this stage, the microcallus tissue can be “disembedded,” 
diluted and surface plated. Once in this form, groWth of the 
diluted microcalli, embedded onto the surface of agar-solidi 
?ed media, is alloWed to proceed until the material is large 
enough to sample. Sampling of the individual, mutated 
microcalli, noW groWn to a diameter of about 0.5 cm, is 
conducted by removing a small portion of tissue, for example, 
With a pair of ring forceps. The tissue sections may be placed 
into Wells of 48-Well microtiter plates Where approximately 
one-half of each sample is used to prepare crude aqueous 
extracts for displacement assays and the remaining portions 
retained in the Wells of the plate. Because the sampling and 
extraction steps are conducted under sterile conditions and in 
callus groWth media, essentially all of the retained material 
can re-groW in the 48-Well dishes, and in this Way a “master” 
mutant tissue library is established. Extracts are prepared, for 
example, by macerating the excised tissue portion in a micro 
centrifuge tube With a micropestle attached to a loW speed 
drill, pelleting the debris by centrifugation at 13,000><g for ten 
minutes and transferring the resulting supernatant to fresh 
tubes. Volumes are precisely set to obtain 700 pL of the 
supernatant, for example, to provide 200-p.L samples for dis 
placement assays in triplicate. 
The basic technology that makes this approach possible is 
the use of mammalian nuclear receptor proteins (N RP) in 
plant cells. These are members of the nuclear steroidhormone 
receptor group, Which include the glucocorticoid (GR), min 
eralocorticoid, estrogen (ER), androgen, and progesterone 
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receptors. After becoming activated by binding speci?c hor 
mone molecules in the cytoplasm, the receptor-ligand com 
plex moves into the nucleus and activates transcription of 
target genes. 
If very feW lines are obtained from the screen that shoW 
constitutive marker expression, e. g., GFP ?uorescence, after 
one or tWo rounds of tagging mutagenesis, it is possible to 
alter the sensitivity of the NRP response (Abe et al., 2001, 
Biochem. Biophys. Res. Commun., 281:122-125). For 
example, it Was shoWn that some polyphenolics, including 
gallocatechins such as (—)-epigallocatechin-3-O-gallate, can 
enhance the activity of a mouse mammary tumor virus pro 
moter, Which is also responsive to glucocorticoid induction. 
This effect Was only seen When a loW level of inducer (200 nm 
dexamethasone) Was present simultaneously (Abe et al. 
2001). Thus, sub-induction levels (i.e., transcriptionally 
induced but beloW the detection limit for visualiZation of GFP 
?uorescence) using dexamethasone or other NRP inducers 
such as (—)-epigallocatechin-3-O-gallate, gallate, catechin, 
and other phenolics can be achieved. For example, the mini 
mum concentration of dexamethasone required for visible 
induction of the glucocorticoid receptor is about 0.1 uM. 
Nuclear receptors play important roles in human physi 
ological processes by acting as sensors to transduce chemical 
signals to changes in gene expression. Their Widespread 
involvement in diverse areas of metabolism, including many 
pathological conditions, make nuclear receptors key thera 
peutic targets for the development of neW drugs. 
Forty-nine distinct nuclear receptors are encoded in the 
human genome. This represents a large set of ligand binding 
domains that could be employed as speci?c targets for the 
discovery of neW biologically active compounds. Included 
among these are nuclear receptors categoriZed as classic 
endocrine receptors mediate the action of many steroid hor 
mones. This group includes the glucocorticoid, mineralcorti 
coid, estrogen, androgen, and progesterone receptors. A sec 
ond nuclear receptor class responds to dietary lipids. 
Members of this category include the peroxisome prolifera 
tor-activated receptor (PPAR), Which respond to various fatty 
acids and is implicated in cellular energy metabolism. Other 
potentially useful mammalian receptors for in situ based plant 
drug discovery include, the liver X receptor, Which functions 
in the regulation of lipid and cholesterol metabolism, the 
famesoid X receptor, involved bile acid/cholesterol homeo 
stasis, and the vitamin D receptor. 
Illustrating the importance of plants as sources of neW 
natural products that function as distinct ligands for such 
receptors is the recent ?nding that guggelsterone, a com 
pound from the Guggul tree, is an antagonist of the farnesoid 
X receptor. When supplied to mice reared on a high-choles 
terol diet, guggelsterone Was found to decrease hepatic cho 
lesterol. This result underscores an important premise of the 
in situ detection strategy, Which is that a variety of additional, 
unknoWn natural ligands exist for nuclear receptors and that 
these may exhibit useful therapeutic potential. 
EXAMPLES 
Example 1 
Production of Transgenic NRP-GFP Reporter Lines 
Using the basic “GVG” glucocorticoid system developed 
by Aoyama, (Aoyama and Chua 1997, Plant J. 11:605-612), a 
construct using the GFP version, smGFP from Davis and 
Vierstra (Davis andVierstra 1998, Plant Mol. Biol., 36:521-8) 
(FIG. 1), Worked Well at the Whole-plant level as detected in 
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seedlings treated With various corticosteroid and steroid 
inducers (FIG. 2). This indicated that a variety of inducers 
lead to a level of GFP expression that can be easily detected in 
various plant cells. The same construct expressed in tobacco 
hoWever, failed to shoW any detectable GFP ?uorescence 
Whatsoever. After con?rming strong transcriptional induction 
using dexamethasone in these transgenic tobacco plants using 
RT-PCR, different GFP versions that permit clear ?uores 
cence detection in tobacco tissue Were evaluated. An Agro 
bacZerium-mediated leaf in?ltration method Was used to e?i 
ciently screen for the most intense ?uorescing GFP derivative 
in tobacco tissue (Yang et al. 2000, Plant J. , 22:543-551). 
Separate constructs Were made for each of three different 
GFP sequences. The original GFP version (Davis andVierstra 
1998) used and tWo modi?ed versions Were placed in front of 
a constitutive promoter (CaMV 35S) along With a transla 
tional enhancer (TE) sequence at the 5' end of each GFP 
coding region (von Amim et al. 1998, Gene, 221:35-43). The 
approach involves the transfer of the 35S::TE::GFP con 
structs, Within the T-DNA of a standard plant transformation 
vector, into plant cells folloWing manual in?ltration of the 
transformed Agrobacleria into the leaf intercellular space 
With a syringe plunger. Nicoliana benlhamiana, a tobacco 
species on Which this transient expression technique had been 
developed and optimiZed, Was ?rst used. TWo GFP 
sequences, mGFP4 and mGFP5 (Siemering et al. 1996, Cur 
rent Biology, 611653-1663), yielded detectable green ?uores 
cence upon excitation With blue light but not With the con 
struct harboring the GFP gene used originally. mGFP5 
shoWed the most intense ?uorescence on repeated experi 
ments. This neW version Was then shoWn to be the only one 
detectable under blue ?uorescent light in the tobacco species 
used for routine protoplast isolation and mutagenesis, N. 
Zabacum SR1. 
PEG-mediated DNA uptake Was then used as a ?nal tran 
sient expression test to determine if GFP ?uorescence could 
be visualiZed at the level of single cells isolated from the SR1 
line (Walden et al. 1994, Plant Mol. Biol., 26:1521-1528). 
Fluorescence microscopy of tobacco cells transfected With 
the mGFP5 version, along With transfected controls, indi 
cated clear GFP ?uorescence that Was Well above back 
ground. 
Stably transformed SR1 tobacco lines prepared With the 
glucocorticoid NRP constructs containing mGFP5 reporter 
genes Were then generated. Shoots from independently trans 
formed lines Were examined for optimal GFP induction char 
acteristics using shoot sections treated With 1 and 10 uM 
dexamethasone for 12 hours. Ten out of 60 independent lines 
shoWed very clear GFP ?uorescence and Were transferred to 
soil to obtain Whole plants. Leaves from some of these lines 
Were used for protoplast isolations to get an early indication 
of GFP induction at the single cell stage (FIG. 3). Six out of 
the ten of these Were then analyZed at the seedling level and 
four lines displayed good induction in all progeny tested at the 
seedling level (using about 50 seeds) and tWo lines exhibited 
the most sensitive induction shoWing clear ?uorescence after 
six hours With 1.0 uM dexamethasone. 
Example 2 
Design and Production of an Estrogen-NRP Reporter 
There is a considerable amount of literature on the use of 
biosensors to detect biological compounds in the environ 
ment. One of the most relevant is the use of genetically 
engineered yeast cells as biosensors for the presence of envi 
ronmental estrogens (Coldham et al. 1997, Environ.Health 
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Perspect, 105:734-42) (these come from several sources 
including plants and pesticides). The principle is based on 
yeast transfected With a mammalian estrogen receptor (ER) 
and ER response element, and this is linked to a gene (the 
yeast URA3 gene) to create a positive selection system. In the 
presence of estrogen there is overexpression of the URA3 
gene and yeast cells survive on synthetic media lacking uracil, 
a condition in Which the background yeast strain (a uracil 
auxotroph) is unable to survive. The transfected yeast is thus 
used as a positive screen for the presence of exogenous estro 
gens. Since endogenous estrogens are not produced in yeast 
this is not a problem for the screen, but plants produce phy 
toestrogens and so the expression of this construct in plant 
cells could provide a means of selecting those cells that over 
produce phytoestrogens. Because of this, and the fact that 
ligands, Which shoW activity at glucocorticoid receptors may 
not be as prominent in plant cells, an estrogen-responsive 
system also utiliZing a mammalian NRP that Will function in 
the same Way as the glucocorticoid-based induction system 
has been constructed. This approach provides a means to 
detect a greater range of plant molecules With ER binding 
activity and these include a range of plant polyphenolic mol 
ecules, including ?avonoids. 
The design of the estrogen NRP-based reporter element 
folloWs the basic format as that for the GR construct (FIG. 1) 
(Aoyama and Chua 1997). In this case, the human estrogen 
receptor hormone binding domain (hER-HBD) that had been 
fused to GAL4 -DNA binding domain and the VP 1 6 transcrip 
tional activation domain Was obtained from D. Picard (Univ. 
ofGeneva) (Louvion et al. 1993, Gene, 13 1 : 129-34). A PCR 
based subcloning strategy Was developed to place this ele 
ment encoding the chimeric estrogen-inducible transcription 
factor (GAL4/hER-HBD/VP16) in front of the 35S promoter 
of CaMV, and to insert the gene encoding mGFP5 (Siemering 
et al. 1996) in front of the 35S minimal promoter-GAL4 
upstream activation sequence (see FIG. 1 for conceptual lay 
out). Testing and validation of this system Was conducted as 
described for the GR-NRP, but using [3-estradiol and other 
estrogens, including plant-derived compounds such as ?a 
vonoids, Which are knoWn to shoW stimulation of estrogen 
responsive element (ERE) promoters (Moosmann and Behl 
1999, Proc. Natl. Acad. Sci. USA, 96:8867-72) 
The system Was validated by testing for the responsiveness 
(i.e., induction of GFP expression by detection of visible GFP 
?uorescence) of several classes of plant molecules. 
Example 3 
Production of a Large Population of Mutant 
Protoplasts from the NRP Transgenic N. Tabacum 
Lines by A grobaclerium-Mediated ATM 
This step includes the isolation of protoplasts from the 
transgenic lines that express the glucocorticoid receptor-GFP 
reporter system i.e., the NRP transgenic lines, and transfor 
mation of these cells by Agrobaclerium-mediated T-DNA 
transfer, for mutagenesis. Leaf protoplasts are prepared by the 
general method as described (Walden et al. 1995, incorpo 
rated herein). Brie?y, 4-5 Week old MS media-groWn (Mu 
rashige and Skoog 1962, Physiol. Plant, 15:473-497) trans 
genic tobacco lines harboring the NRP-GFP detection system 
are used as a source of leaf material for protoplast isolation. 
Leaf pieces from sterile-groWn plants are digested by over 
night incubation in a 1.5% cellulase-0.5% pectinase (Sigma) 
mixture in plant cell culture medium (K3 media) at 260 C. in 
the dark. Released protoplasts are recovered by sieving 
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through a 105 pm mesh and puri?ed by repeated loW speed 
centrifugation (2000 rpm, in a sWing-out rotor), conditions 
Whereby intact, viable protoplasts ?oat and nonviable cells 
and debris pellet. Protoplasts are incubated for further steps in 
culture dishes at 1><106 cells per 10 mL media. 
Transformation With the activator T-DNA tag to 
mutageniZe the plant cells is performed by co-cultivation With 
Agrobaclerium Zumefaciens, strain GV3101 (KoncZ and 
Schell 1986, Mol. Gen. Genet., 204:383-396), harboring the 
plasmid pPCVlCEn4HPT (provided by R. Walden), Which 
contains the activation T-DNA tagging element (FritZe and 
Walden 1995, Meth. Mol. Biol., 44:281-94). Freshly groWn 
bacterial cells are added directly to six to eight day-old pro 
toplast cultures in a ratio of 100:1 bacteria to protoplast cells. 
Co-cultivation is conducted at 260 C. in the dark for 48 hours. 
At the end of the incubation period, protoplasts are Washed 
three times in W5 media (154 mM NaCl, 125 mM 
CaCl2~2H2O, 5 mM KCl, 5 mM glucose, pH 5.6-6.0) by 
centrifugation in a sWing-out rotor at room temperature. Pro 
toplasts are resuspended in 0.4 M sucrose K3 media to pro 
duce a ?nal concentration of 1><106 protoplasts per mL. One 
mL of protoplast suspension is transferred to a standard (100 
mm) petri dish and cultured in a ?nal volume of 10 mL of 0.4 
M sucrose K3 media containing antibiotic selection against 
A grobaclerium cells (cefotaxime 500 pg mL_l) as Well as the 
presence of hormones to maintain cells in a dedifferentiated 
state [auxin (naphthalene acetic acid, NAA) 1.0 pg mL‘1 and 
cytokinin (kinetin) 0.2 pg mL_l]. Hygromycin (15 pg mL_l) 
or kanamycin (20 pg mL'l), depending on the selectable 
markers present on additional versions of the tagging element 
We have produced, is also added to the incubation media to 
select for the protoplasts transformed With the activation 
tagging vector. Control transformations are also performed 
With vectors lacking the enhancer sequences, Which provide a 
means to assess false positives in a given co-cultivation 
experiment. 
Culturing of protoplasts into microcalli is continued by 
embedding the cells in 0.3% loW-gelling temperature agarose 
(SeaPlaquee®, FMC Bioproducts, Rockland, Me.). K4 
media, a neW media We have adopted for subsequent micro 
callus culturing because of more vigorous groWth at this 
stage, is then added to the petri dishes containing the soft 
agarose-embedded microcalli. This media also contains all 
hormones and selective antibiotics as noted above, but 
replaces the nitrate salts (NH4NO3 and KNO3) used in the 
conventional K3 plant groWth media With glutamine, aspar 
agine and arginine (FritZe et al. 1995, Plant 1., 71261-271). 
Following protoplast embedding, the K4 media is reduced in 
osmolarity at 0.1 M increments, (starting at 0.4 M sucrose, 
~580 mOsm) on a Weekly basis by changing the liquid phase 
media over the soft agarose-embedded cells. Once microcalli 
are established (usually four to ?ve Weeks), they are released 
from the agarose by gentle maceration and dilution. Micro 
calli are further cultured by “surface plating” the transformed 
tissue to 0.1 M K4 media solidi?ed With agarose in 150 mm 
dishes. Dilutions are made empirically to adjust the number 
of individual microcalli on each dish to densities su?icient to 
enable clear separation for microscopic screening and for 
continued groWth of the microcalli up to the stage of sam 
pling. 
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Example 4 
Isolation of those Cells (or Microcalli) 
over-expressing GFP by Micro-Manipulation under 
Fluorescence Microscopy 
Screening for the presence of elevated plant metabolites by 
?uorescence microscopy can occur soon after embedding 
microcalli in agarose. The siZes of the microcalli at this stage 
are usually highly variable. Because of this it is advisable to 
adjust the density during embedding as indicated above to 
enable the clear visualiZation of smaller microcalli that might 
be obscured by larger calli.VisualiZation of GFP ?uorescence 
is conducted by placing the petri dishes in Which the micro 
calli is embedded directly on the stage of a Nikon Eclipse TE 
200 inverted micro scope, equipped With a super high pres sure 
mercury vapor lamp and poWer supply and ?tted With ?lter 
blocks for GFP excitation and emission (excitation Wave 
lengths: 470-490 nm; emission Wavelengths: 520 nm and 
above). Excitation and the resulting ?uorescing illumination 
pass directly through the polystyrene lids of the dishes, 
enabling screening to be conducted Without having to open 
them and exposing the tissue to non-sterile conditions. Any 
?uorescing microcalli are marked on the dish and monitored 
for ?uorescence regularly as they develop. Controls alWays 
include transgenic tissue at the same stage to Which various 
concentrations (0.1, 1.0 uM) of inducers, generally dexam 
ethasone, Will be added. Microcalli that exhibit stable, con 
tinuous ?uorescence under blue-Wavelength light at later 
stages of groWth are considered positives for the primary 
screen and are isolated by manual transfer When the material 
has groWn to appropriate sizes. No ?uorescence has been 
detected in the absence of exogenously applied chemical 
inducers. Thus We expect a loW level of background false 
positives for the corticosteriod receptor screen. 
Example 5 
Establishment of Cells as Mutant Lines 
The activation-tagged plant cells identi?ed from the pri 
mary screen on the surface of agar-solidi?ed media are fur 
ther groWn to obtain distinct “macrocalli” for sampling and 
extract preparation. Continuous monitoring for GFP ?uores 
cence is conducted microscopically as the callus tissue devel 
ops. Sampling is initiated When the surface-plated callus 
material attains a siZe of approximately 0.5 to 1.0 cm in 
diameter. Individual calli are sampled by excising approxi 
mately 50 mg from the callus and performing a “partial” 
maceration of this tissue in Wells of a 48-Well microtiterplate. 
The partial maceration is performed in fresh groWth media, 
enabling a small proportion of cells from the callus to remain 
intact and viable. The supernatant extract resulting from this 
tissue maceration is removed to complete the extraction and 
then centrifuged to remove debris. Liquid groWth media is 
added to each of the 48 Wells in the plate to replace this and 
these are further incubated to alloW for recovery of the 
remaining intact cells. Because all of these steps are con 
ducted under sterile conditions, the partially disrupted calli 
are able to groW, and this in effect establishes the “master” 
library by Which the viable mutageniZed material can be 
maintained for several months. Since displacement activity 
data from the pharmacological screen is usually obtained 
Within one to tWo Weeks of sampling, the material, arrayed in 
the 48-Well microtiter plates, can be used to recover any 
con?rmed positives. Thus, by this means, sampling, extract 
preparation and establishment of a viable library of the 
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mutageniZed population is conducted in a single step. 
Throughout the recovery process, as the mutated calli are 
continuously monitored as noted, positive mutants are con 
?rmed by detecting GFP ?uorescence in microcalli that has 
redoubled their mass on the surface of agar-solidi?ed media 
after being divided into small pieces. 
Example 6 
Use of Extracts of Mutant Microcalli to Con?rm 
Increased NRP Biological Activity in a Conventional 
Pharmacological Radioligand Binding Screen 
GFP-positive tobacco cells derived from the primary 
screens are arrayed as microcalli in 48-Well microtiter culture 
dishes. Lines groWn in this format can be maintained for 
periods of four to six months Without the need for further 
transfers or additional manipulations. Thus the culture library 
provides a master set of mutated material during Which the 
secondary analysis is conducted. The callus library also 
serves to continually propagate the mutated material as undif 
ferentiated tissue as a contingency in the event that regenera 
tion of any positive callus clones to Whole plants is not pos 
sible or e?icient. In such cases, it is possible to isolate 
genomic DNA from callus tissue for Southern analysis and 
gene cloning procedures. 
The secondary screen consists of pharmacological assays 
conducted on extracts prepared from callus tissue in the mas 
ter library. A glucocorticoid receptor binding assay is used to 
test extracts of cultures for production of GR ligands. The 
methods for radioligand binding to the glucocorticoid recep 
tor are modi?ed from described generalized procedures (Kam 
et al. 1993, J. Immunol., 151:3460-66; Soldin et al. 1992, 
Ther. Drug Monit., 141164-68, both incorporated herein by 
reference). Radioligand binding is performed to con?rm cor 
relation betWeen ligand binding and reporter activity, as Well 
as to assess the presence of endogenous glucocorticoids in 
transgenic cultures. 
Mammalian steroid receptors are prepared by homogeniZ 
ing 1 g of ?nely minced rat liver tissue in a solution containing 
0.32 mM sucrose, 0.02 mM Tricine, 2mM CaCl2, and 1 mM 
MgCl2 (pH 7.4), in a hand-held glass homogeniZer and apply 
ing approximately 30 strokes With a Te?on pestle. The homo 
genate is centrifuged at 100,000><g at 40 C. for one hour and 
the supernatant, containing the cytosolic fraction, is retained. 
Protein concentrations are measured using a commercial kit 
based upon a modi?ed LoWry method (Sigma, St Louis, Mo .). 
The radiolabeled glucocorticoid ligand is prepared from 
stock solutions of [3H]-dexamethasone (Amersham, Arling 
ton Heights, Ill.) by addition to 1 mL of 95% ethanol and 9 mL 
0.32 mM sucrose. This Working stock solution is then diluted 
for a ?nal (per Well) concentration of 10 nM. The radioligand 
binding assay is conducted by adding unlabeled and radiola 
beled glucocorticoids in ethanol to 10 mL polypropylene 
tubes and evaporating under nitrogen gas. 500 ML aliquots of 
the glucocorticoid receptor preparation are added to each 
tube, and the tubes are incubated for three hours at room 
temperature. Extracts prepared from individual microcalli 
displaying stable GFP ?uorescence are used in competition 
binding experiments to determine if glucocorticoid small 
molecule activity is elevated. All experiments are run in dupli 
cate determinations. The binding reaction is terminated by the 
addition of 5 mL of ice-cold, 5 mM HEPES buffer containing 
0.2 mM EDTA (pH 7.4) and the tube contents are ?ltered 
through a nitrocellulose ?lter. Data are collected as counts per 
minute (CPM) With a Packard Tricarb 2100TR liquid scintil 
lation vial counter. Speci?c binding is de?ned as total binding 
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minus non-speci?c binding, (the latter is determined in the 
presence of 10 uM cold dexamethasone). Data are presented 
as the mean of pooled replicates :SE. Group means are com 
pared by analysis of variance and multiple range testing. 
Quanti?cation of the speci?c binding activity is done, for 
example, by comparisons to standard curves generated by 
plotting the CPM of [3H]-dexamethasone standards versus 
the concentration of dexamethasone (pg L_l). An activity 
table of steroid standards (hydrocortisone, prednisone, 
betamethasone, triamcinolone, and [3-estradiol as a negative 
control) Will then be generated, expressing activity as units of 
dexamethasone activity equivalents. Concentrations of 
unknoWn samples are then estimated based on “dexametha 
sone equivalents”. Non-speci?c binding is determined as pre 
viously described (expected to be approximately 10%) and 
from callus extracts cleared of polyphenolics as Well as glu 
cocor‘ticoids. These glucocor‘ticoid-free extracts are prepared 
from plant cell culture extracts by centrifugation at 5000><g 
for ?ve minutes to remove any cellular debris, and mixing the 
resulting supernatant (1 mL) With 100 mg activated charcoal. 
After incubation at room temperature for tWo hours, the char 
coal is removed by Washing 2>< With centrifugation at 
40,000><g for 20 minutes. This methodology is a variation of 
a Wide-ranging number of methodologies utiliZed clinically 
to estimate blood steroid levels of patients undergoing steroid 
therapy. 
Any GFP-positive lines that shoW elevated activity in the 
speci?c pharmacological binding assays are folloWed up by 
GC/MS analysis of cultures overproducing GR ligands. The 
“surface-plating” regime developed during the microcallus 
screen for alkaloidal activity, are applied to individual callus 
clones to amass tissue for extractions. The exclusive use of 
surface-groWn material at these stages (as opposed to bulking 
up material by liquid culture groWth) provides a means to 
minimize secondary, somatic cell mutations that are possible 
if the plant tissue is maintained as rapidly groWing undiffer 
entiated cultures for prolonged periods (Phillips et al. 1994). 
Surface-grown callus tissue from individual lines are used 
for preparing concentrated extracts for GC analysis. Using 
described methods (Bruni et al. 2001), sterols are extracted by 
placing 5 g of lyophiliZed callus tissue in 100 mL methanol 
and sonicated by treating With continuous, loW poWer ultra 
sound for 30 min (SonicatorTM, Heat Systems-Ultrasound, 
Inc.). The extraction procedure is performed in darkness 
under constant temperature of 25° C. The resulting extract is 
evaporated to dryness using a rotary evaporator. The resulting 
residue is then Weighed, and 50 mg of the sample is cold 
saponi?ed by shaking the sample constantly for 24 hours at 
room temperature (25° C.) With 5 mL of 1 M methanolic 
KOH. The solution is then extracted three times With 2 mL 
hexane and 0.2 mL ethanol. The hexane fraction is dried 
under nitrogen and the unsaponi?able fraction is silaniZed at 
room temperature With a 2-mL mixture containing pyridine/ 
hexamethlydisilaZine/trimethylchlorosilane (5:2:1). After 1 
one hour incubation, the liquid is evaporated under nitrogen 
in an 80° C. Water bath then extracted three times With 0.3 mL 
hexane. The resulting organic fractions are combined and 
centrifuged and the resulting supernatant is used directly for 
GC analysis. One microliter of this sample is injected into an 
Agilent 6890 GC containing a DB-5MS column (30 m><0.25 
mm><0.25 pm) with ?ame ioniZation detection using an Agi 
lent 7360 autosampler system. Chromatographic separation 
is obtained by running an oven temperature program that 
heats from 2200 C. to 300° C. at 5° C. per min With injector 
and detector temperatures set at 300° C. and 350° C., respec 
tively. The proportions of the major sterol peaks are estimated 
by generating concentration curves using available standards 
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and comparing pro?les of Wild-type and mutant callus 
extracts to these. While We can quantify knoWn steroid com 
ponents using these methods, the possibility of enhanced GFP 
?uorescence and displacement activity being due to the accu 
mulation of other, perhaps uncharacteriZed, metabolites 
makes the examination of these pro?les crucial. For example, 
if extracts from mutant tissue displaying reproducible dis 
placement activity fail to shoW any quantitative differences in 
major peaks compared to Wild-type extracts, the chromato 
graphic data Will need to be carefully scrutiniZed for the 
presence of neW peaks, or minor peaks that are of greater 
abundance in mutant extracts. These previously absent or 
trace-level peaks Will then be examined as thoroughly as 
possible by GC-MS analysis. This Will be performed on an 
Agilent 6890 GC system coupled to an Agilent 5973 mass 
selective detector. The conditions used are identical to those 
described for GC-FID analysis, With the folloWing modi?ca 
tions. The mass spectra are recorded betWeen 40 and 600 amu 
With an electron energy of 70 eV. The injector temperature 
and ion source temperature are set at 300° C. Qualitative 
analysis is based upon comparison of retention times and 
spectra With corresponding data logged in the Wiley Library 
mass spectral database. 
Example 7 
Genomic Cloning Techniques (Plasmid Rescue, 
Genomic Walking) to Recover Genomic DNA 
Adjacent to the Activation T-DNA Tags from the 
Individual Lines 
The mo st straightforward and ef?cient technique for clon 
ing plant genomic DNA ?anking the T-DNA insertion site is 
plasmid rescue. This approach relies on the bacterial origin of 
replication and the ampicillin antibiotic resistance gene 
encoded Within the plasmid that is incorporated into the acti 
vation-tag T-DNA element (Walden et al. 1995; Weigel et al. 
2000; incorporated herein). This method is applied after ?rst 
examining the nature of the insert in a given mutant line by 
Southern blot analysis. Genomic DNA is isolated from young 
plant or callus tissue, Whichever is the most abundant or 
available, and Southern analysis is conducted by probing With 
fragments of speci?c sequences Within the T-DNA. A kana 
mycin resistance gene sequence and a second probe contain 
ing sequences Within the bacterial plasmid located Within the 
activation T-DNA are typically used. Screen-positive plant or 
callus genomic DNA digested With restriction endonucleases 
that do not cut Within the T-DNA element (e.g., EcoRI and 
Notl) is used in a ?rst analysis. Hybridization patterns indi 
cating single insertions and siZes greater than that of the 
5.7-kb T-DNA, are candidates for plasmid rescue. We have 
had success in performing plasmid rescue using genomic 
DNA of the proper siZe range eluted directly from nucleic 
acid grade agarose gels as Well as using total genomic DNA 
Without prior electrophoretic separation. After puri?cation 
and concentration of the digested DNA, plasmid rescue is 
conducted by ligating the digested genomic DNA en masse to 
recirculariZe all of the digested fragments and transforming 
these by electrporation (BioRad Gene Pulser) into a recom 
bination-de?cient E. coli strain (SURE® cells, Stratagene) to 
prevent rearrangements due to the presence of the multimer 
iZed enhancers (Weigel et al. 2000). Plasmids isolated from 
the resulting ampicillin-resistant colonies are then examined 
using standard methods and DNA sequencing. There are also 
restriction enZyme sites that can be employed to rescue 
sequences to the right or left half of the T-DNA. That is, there 
are sites located on either side of the integrated plasmid 
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sequences Within the T-DNA that can be used to recover 
genomic DNA only from one side of the T-DNA (Walden et 
al. 1995; Weigel et al. 2000). These various cloning options 
usually Will permit the isolation of at least some clones con 
taining several kb of genomic DNA. In cases Where these 
approaches do not lead to a suf?cient amount of recovered 
DNA, even a feW hundred base pairs can be used to probe 
genomic libraries to obtain larger, contiguous fragments. In 
addition, because it is possible to elute speci?c siZe fractions 
from agarose gels and there is an e?icient means to function 
ally test DNA by uptake into transgenic cells, rescued T-DNA 
tags associated With more than one locus can be tested by 
independently recovering genomic DNA in separate proce 
dures, and then test these individually-derived clones for 
activity. 
Example 8 
Con?rmation of Gene Function by Re-Incorporation 
of Isolated DNA into Protoplasts from the Original 
Transgenic Line 
The ultimate con?rmation that the recovered tagged gene is 
responsible for the small-molecule phenotype is by func 
tional analysis of the rescued DNA. Genomic DNA clones 
that are associated With the CaMV 35S promoter enhancers 
are used. Genomic fragments that are not directly associated 
With the enhancers, for example are derived from the left half 
of the T-DNA, Which do not contain the enhancer sequences, 
or are isolated from genomic libraries, are incorporated into 
vectors containing the enhancers to cause the activation of 
any genes present. Such vectors have been constructed by 
Weigel and others, Which have multiple cloning sites Within a 
T-DNA element containing the 35S enhancers and a plant 
selectable marker (Wei gel et al. 2000) and can be used herein. 
The fastest means of conducting this functional test With such 
cloned plant DNA is by transient expression analysis after 
polyethylene glycol (PEG) -mediated DNA uptake (Walden et 
al. 1995). This method is carried out With freshly prepared 
protoplasts from leaves of the same NRP transgenic plants 
used for the mutagenesis and screening, Which contain the 
hormone receptor based detection system. DNA uptake into 
protoplasts is performed by ?rst preparing the isolated plant 
cells by Washing in W5 media in standard polystyrene cen 
trifuge tubes, and resuspending in a solution containing 450 
mM mannitol, 15 mM MgCl2, 0.1% MES (pH 5.6) to a ?nal 
concentration of 1><106 protoplasts per mL. This is used to 
prepare 300 pL aliquots of the protoplast suspension, Which 
are heat shocked at 45° C. for ?ve minutes folloWed by 
cooling on ice for tWo minutes. At room temperature, 10 pL of 
a DNA sample is added at 1 pg pL_l, and incubated for ten 
minutes. At this point a PEG-containing solution consisting 
of 0.1 M Ca(NO3)2-4H2O, 0.4 M mannitol, 40% PEG 3350 
(Sigma) (pH 7-9), is added and mixed to the cells and DNA 
and incubated 20 minutes at room temperature. After this 
incubation, 4.4 mL of 0.4 M sucrose-K3 groWth media, con 
taining required groWth factors (NAA 1 pg pL_1, 0.2 pg pL‘l 
kinetin) is added. The protoplasts are then transferred to 
60-mm petri dishes, sealed With para?lm and incubated at 260 
C. in the dark for tWo days. After this time the protoplasts are 
placed in the light (20 pE m-2 s_l) in an incubator also at 260 
C. Examination for GFP ?uorescence can occur at this stage 
and can be monitored over the next several days. Appropriate 
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controls, including plasmids containing enhancer sequences 
but no genomic DNA are included. After ?ve days, cells can 
be embedded into agarose, as conducted With Agrobacle 
rium-transformed cells, to enable continued groWth under 
selective conditions, but We have found that for examining the 
effect of the inserted DNAs in larger, callus tissue, it is more 
e?icient to proceed With standard Agrobacerium-mediated 
transformation into Whole tobacco leaves based on the “leaf 
dip” transformation protocol. This gives stably transformed 
callus faster than Waiting for the single cells from DNA 
uptake to groW into microcalli. Moreover, for DNA uptake 
into protoplasts, expression is transient, and it may be neces 
sary to evaluate the effect of the transferred sequences in the 
larger, stably expressed callus format. Another factor is the 
fact that this tissue is also the type on Which the primary 
screen is conducted. HoWever, the activity screen is simply by 
examination under blue-Wavelength light and thus can also be 
monitored continuously and at very early stages. 
Example 9 
Determination of All Genomic DNA Sequence 
Isolated by High Throughput DNA Sequencing 
The complete nucleotide sequence of all rescued or other 
Wise recovered genomic DNA associated With the T-DNA 
tags may be obtained. A given genomic clone may not nec 
essarily be contiguous, as separate methods may be employed 
to recover a suf?ciently siZed portions of DNA, such as tWo 
stages of plasmid rescue, or genomic screening approaches, 
as described in Objective 5, but these Will all be assembled to 
provide a fully sequenced genomic fragment for analysis. 
Elucidation of the complete sequence Will only be conducted 
on clones examined for proper restriction digest patterns and, 
Where necessary, additional analysis by PCR, particularly for 
regions close to the T-DNA borders, Where there can be 
incomplete transfer mainly at the 5' end, or the introduction of 
extra DNA. For example, sequences derived from the Agro 
baclerium binary vector “backbone” can be transferred into 
the genome in addition to the T-DNA, and can obscure the 
precise insertion point into the genomic DNA. 
The basic strategy to be folloWed Will be to mechanically 
shear each recovered clone using a “HydroShear®” (Gen 
eMachines, San Carlos, Calif.) high pressure shearing device 
into random fragments centered at 1.8-kb, and cloning these 
into suitable, blunt-end digested and phosphatase-treated 
vectors (Oefner et al. 1996). Colonies harboring recombinant 
plasmids after transformation With ligated mixtures of clones 
Will be automatically gridded to hybridization membranes 
and probed With sequences from Within the activation-tag 
ging element (e.g., the hygromycin resistance gene, 35S 
CaMV enhancer sequences) to identify clones containing 
T-DNA. Recombinant clones shoWing the absence of the 
main portion of the T-DNA are sequenced. 
All output from the ABI automated DNA sequencers is 
fully readable using LaserGene (DNASTAR, Madison, Wis.) 
sequence analysis softWare consisting of SeqMan, EditSeq, 
and MegAlign programs, among others. This and the related 
packages of DNA analysis programs have been in use in our 
laboratories for the past several years and therefore all of the 
respective laboratory members have experience With the pro 
grams. These programs are used extensively to compile, 
assemble and analyZe sequences, including providing direct 
formats to the National databases. 
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Example 10 
Further Characterization of Genes in Regenerated 
Mutant Plants to Establish Whether the Gene 
In?uences Product Synthesis at this Level 
As noted in Example 4, early in the process to con?rm any 
?uorescing mutated callus clone, available material is trans 
ferred to shoot-inducing media (MS media plus 0.10 mg L-l 
NAA 0.5 mg L-l benZylaminopurine). In addition, genetic 
material introduced into the NRP-based detector lines during 
the evaluation of isolated genomic sequences provides neW 
stably transformed lines that can be evaluated for GFP ?uo 
rescence throughout their development into Whole plants. 
This provides tWo important levels of analysis for the 
sequences that are identi?ed. One is the examination of lines 
derived independently that overexpress genes associated With 
an enhancer, and the other are lines derived from the original, 
GFP-positive, microcallus clones. 
Example 11 
Screening Using the Human Estrogen Detector 
System in Arabidopsis 
Putative mutants that accumulate phytoestrogens have 
been identi?ed by screening mutageniZed populations of a 
transgenic Arabidopsis line harboring a human nuclear recep 
tor system. The primary genetic screen Was conducted by 
examining young seedling roots for expression of the green 
?uorescent protein by ?uorescence microscopy. Out of 
approximately 8,000 lines screened, a subpopulation of about 
49 lines Were scored as putative positive on this basis and used 
to generate progeny to perform a secondary screen. A portion 
of this population has been examined and some (4-5) indi 
viduals exhibited GFP expression as detected by visual 
inspection. Whole-seedling extracts Were prepared from this 
?rst group and used to determine phytoestrogen “activity”. 
Analysis by estrogen binding displacement assays indicated 
that elevated levels of [3-estradiol-equivalent activities Were 
detected in tWo lines compared to a negative control, as indi 
cated in Table I. 
TABLE I 
Binding Activity in Putative (GFP expression-positive) Lines 
Line: 
4 5 Neg. control 
Approx. Activity* (nM) 30 10 0.01 
*Activity expressed as [i-estradiol activity equivalents 
Thus, use of a mammalian nuclear receptor in transgenic 
plants demonstrates the versality of the invention for screen 
ing mutageniZed populations of seedlings or plant cells by the 
direct detection of biologically active metabolites. 
What is claimed is: 
1. A high throughput screening method for identifying 
plant cells that are the source of compounds that interact With 
a mammalian estrogen receptor ligand binding domain com 
prising, 
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(l) transforming an Arabidopsis or Nicoliana Zabacum 
plant With a vector having an estrogen receptor system 
comprising a constitutive promoter operably linked to a 
nucleotide sequence encoding a trimeric transcription 
factor comprising as operatively linked components a 
mammalian estrogen receptor ligand binding domain, a 
transcription factor DNA binding domain and a transac 
tivating transcriptional activator domain; and a gene 
encoding a visible marker operably linked to a transcrip 
tion activator sequence and a promoter, to obtain a trans 
genic plant; 
(2) isolating protoplasts from the transgenic plant of step 1 
that express the estrogen receptor system and the gene 
encoding the visible marker; 
(3) mutageniZing the protoplasts of step 2 via T-DNA tag 
ging mutagenesis to form mutageniZed protoplasts; 
(4) culturing the mutageniZed protoplasts of step 3 into 
microcalli; and 
(5) selecting microcalli of step 4 that overexpress the vis 
ible marker gene in comparison to a control transgenic 
microcallus. 
2. The method of claim 1 further comprising 
(a) preparing an extract of cells removed from a microcal 
lus that overexpresses the visible marker gene, Wherein 
removal of the cells does not destroy the microcallus; 
(b) testing the extract of step (a) for the presence of small 
molecules and/or compounds that bind to the estrogen 
receptor ligand binding domain. 
3. The method of claim 2 further comprising recovering 
genomic DNA adjacent to and Within about 5.7 kb of an 
activation T-DNA tag in protoplasts or callus tissue that con 
tain small molecules or compounds that activate the estrogen 
receptor ligand binding domain. 
4. The method of claim 3 further comprising cloning the 
genomic DNA that is recovered into a second vector compris 
ing enhancer sequences such that the enhancer sequences are 
operably linked to the genomic DNA; transforming proto 
plasts isolated from plants transformed With the vector of step 
(1) With the second vector; and monitoring the protoplasts for 
expression of the visible marker gene. 
5. The method of claim 1 Wherein the plant is a tobacco 
plant. 
6. The method of claim 1 Wherein the plant is Arabidopsis. 
7. The method of claim 1 Wherein the visible marker gene 
encodes green ?uorescent protein. 
8. The method of claim 2 Wherein the binding of the small 
molecule or compound results in activation of the estrogen 
receptor. 
9. The method of claim 2 Wherein binding to the mamma 
lian estrogen receptor is detected in plant cells or tissues by 
the corresponding activation of a visible marker gene. 
10. The method of claim 2 Wherein con?rmation of small 
molecule activity is by a radioligand displacement assay. 
11. The method of claim 1 Wherein the mutageniZed pro 
toplasts are exposed to an inducer of the estrogen receptor 
ligand binding domain. 
12. The method of claim 11 Wherein the inducer is [3-es 
tradiol. 
13. A high throughput screening method for identifying 
cells that are the source of plant small molecules or com 
pounds capable of activating a mammalian estrogen receptor 
protein comprising, 
(1) transforming anArabidopsis or a N Zabacum plant With 
a vector comprising a constitutive promoter operably 
linked to a nucleotide sequence encoding a trimeric tran 
scription factor comprising as operatively linked com 
ponents a human estrogen receptor hormone binding 
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domains, a yeast GAL4-DNA binding domain and a 
transactivating herpes simplex V16transcriptional acti 
Vator domain; and a gene encoding a Visible marker 
operably linked to a transcription activator sequence and 
a promoter, to obtain a transgenic plant; 
(2) isolating protoplasts from the transgenic plant of step 1 
that express the gene encoding the Visible marker; 
(3) mutageniZing the protoplasts of step 2 Via T-DNA tag 
ging mutagenesis to form mutageniZed protoplasts; 
20 
(4) culturing the mutageniZed protoplasts of step 3 into 
microcalli; and 
(5) selecting microcalli of step 4 that overexpress the Vis 
ible marker gene in comparison to a control transgenic 
microcallus. 
14. The screening method of claim 13 Wherein the consti 
tutive promoter of the Vector is the 35S promoter of the 
cauli?ower Mosaic Virus (CaMV). 
* * * * * 
